🇺🇸 FDA
Pipeline program

DOXORUBICIN, Pralatrexate, PREDNISONE, Belinostat, VINCRISTINE SULFATE, CYCLOPHOSPHAMIDE

SPI-BEL-301

Phase 3 small_molecule active

Quick answer

DOXORUBICIN, Pralatrexate, PREDNISONE, Belinostat, VINCRISTINE SULFATE, CYCLOPHOSPHAMIDE for Peripheral T-Cell Lymphoma is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Peripheral T-Cell Lymphoma
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials